This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Al Ghobain M., Algazlan S.S., Oreibi T.M.: Asthma prevalence among adults in Saudi Arabia. Saudi Med J. 39, 179–184 (2018)Al GhobainM.AlgazlanS.S.OreibiT.M.Asthma prevalence among adults in Saudi ArabiaSaudi Med J39179184201810.15537/smj.2018.2.20974Search in Google Scholar
Al-Moamary M.S., Al-Hajjaj M.S., et al.: The Saudi initiative for asthma – 2021 update: Guidelines for the diagnosis and management of asthma in adults and children. Ann Thorac Med. 16, 4–56 (2021)Al-MoamaryM.S.Al-HajjajM.S.The Saudi initiative for asthma – 2021 update: Guidelines for the diagnosis and management of asthma in adults and childrenAnn Thorac Med16456202110.4103/atm.ATM_697_20Search in Google Scholar
Zaki A.M., van Boheemen S., Bestebroer T.M., Osterhaus A.D.M.E., Fouchier R.A.M.: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 367, 18–1820 (2012)ZakiA.M.van BoheemenS.BestebroerT.M.OsterhausA.D.M.E.FouchierR.A.M.Isolation of a novel coronavirus from a man with pneumonia in Saudi ArabiaN Engl J Med367181820201210.1056/NEJMoa1211721Search in Google Scholar
Wang Y., Wang Y., Chen Y., Qin Q.: Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol. 92, 568–576 (2020)WangY.WangY.ChenY.QinQ.Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measuresJ Med Virol92568576202010.1002/jmv.25748Search in Google Scholar
Huang C., Cao B.: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497–506 (2020)HuangC.CaoB.Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaLancet395497506202010.1016/S0140-6736(20)30183-5Search in Google Scholar
Shang J., Wan Y., Luo C., Ye G., Geng Q., Auerbach A., Li F.: Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci USA, 26, 117, 11727–11734 (2020)ShangJ.WanY.LuoC.YeG.GengQ.AuerbachA.LiF.Cell entry mechanisms of SARS-CoV-2Proc Natl Acad Sci USA26,1171172711734202010.1073/pnas.2003138117Search in Google Scholar
Jackson C.B., Farzan M., Chen B., Choe H.: Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 23, 3–20 (2022)JacksonC.B.FarzanM.ChenB.ChoeH.Mechanisms of SARS-CoV-2 entry into cellsNat Rev Mol Cell Biol23320202210.1038/s41580-021-00418-xSearch in Google Scholar
Zhong N.S., Guan Y. et al.: Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February 2003. Lancet, 362, 1353–1358 (2003)ZhongN.S.GuanY.Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February 2003Lancet36213531358200310.1016/S0140-6736(03)14630-2Search in Google Scholar
Bhat E.A., Sajjad N., Ali A., Aldakeel F.M., Mateen A., Alqahtani M.S., Syed, R.: SARS-CoV-2: insight in genome structure, pathogenesis and viral receptor binding analysis-an updated review. International immunopharmacology, 95, p. 107493 (2021)BhatE.A.SajjadN.AliA.AldakeelF.M.MateenA.AlqahtaniM.S.SyedR.SARS-CoV-2: insight in genome structure, pathogenesis and viral receptor binding analysis-an updated reviewInternational immunopharmacology95107493202110.1016/j.intimp.2021.107493790446533721758Search in Google Scholar
Morens D.M., Breman J.G., Calisher C.H., Doherty P..C, Hahn B.H., Keusch G.T., Kramer L.D., LeDuc J.W., Monath T.P., Taubenberger J.K.: The origin of COVID-19 and why it matters. Am J Trop Med Hyg. 103, 955–959 (2020)MorensD.M.BremanJ.G.CalisherC.H.DohertyP.C.HahnB.H.KeuschG.T.KramerL.D.LeDucJ.W.MonathT.P.TaubenbergerJ.K.The origin of COVID-19 and why it mattersAm J Trop Med Hyg103955959202010.4269/ajtmh.20-0849747059532700664Search in Google Scholar
Lee S.C., Son K.J., Han C.H., Jung J.Y., Park S.C.: Impact of comor bid asthma on severity of coronavirus disease (COVID-19). Nat Sci Rep. 10, 21805 (2020)LeeS.C.SonK.J.HanC.H.JungJ.Y.ParkS.C.Impact of comor bid asthma on severity of coronavirus disease (COVID-19)Nat Sci Rep1021805202010.1038/s41598-020-77791-8773345333311519Search in Google Scholar
Lee S.C., Son K.J, Han C.H., Park S.C., Jung J.Y.: Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South Korea. Nat Sci Rep. 11, 3735 (2021)LeeS.C.SonK.J.HanC.H.ParkS.C.JungJ.Y.Impact of COPD on COVID-19 prognosis: A nationwide population-based study in South KoreaNat Sci Rep113735202110.1038/s41598-021-83226-9788098533580190Search in Google Scholar
COVID-19 Stats – Realtime coronavirus statistics with charts (epidemic-stats.com) Accessed on: 16th June 2021COVID-19 Stats – Realtime coronavirus statistics with charts (epidemic-stats.com)Accessed on:
16th June 2021Search in Google Scholar
Meo S.A.: COVID-19 pandemic: Saudi Arabia's role at national and international levels. J Diabetes Sci Technol. 14, 758–759 (2020)MeoS.A.COVID-19 pandemic: Saudi Arabia's role at national and international levelsJ Diabetes Sci Technol14758759202010.1177/1932296820930068767319432506934Search in Google Scholar
Gao Y., Akdis C.A. et al.: Risk factors for severe and critically ill COVID-19 patients: a review. Allergy, 76, 428–455 (2021)GaoY.AkdisC.A.Risk factors for severe and critically ill COVID-19 patients: a reviewAllergy76428455202110.1111/all.1465733185910Search in Google Scholar
Oran D.P., Topol E.J.: The proportion of SARS-CoV-2 infections that are asymptomatic: A systematic review. Ann Intern Med. 174, 655–662 (2021)OranD.P.TopolE.J.The proportion of SARS-CoV-2 infections that are asymptomatic: A systematic reviewAnn Intern Med174655662202110.7326/M20-6976783942633481642Search in Google Scholar
Kimball A., Jernigan J.A. et al.: Public Health-Seattle & King County; CDC COVID-19 investigation team. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a ong-term care skilled nursing facility – King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep. 69, 377 381 (2020)KimballA.JerniganJ.A.Public Health-Seattle & King County; CDC COVID-19 investigation team. Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a ong-term care skilled nursing facility – King County, Washington, March 2020MMWR Morb Mortal Wkly Rep69377381202010.15585/mmwr.mm6913e1711951432240128Search in Google Scholar
Lavezzo E., Crisanti A. et al.: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo. Nature, 584, 425–429 (2020)LavezzoE.CrisantiA.Suppression of a SARS-CoV-2 outbreak in the Italian municipality of VoNature584425429202010.1038/s41586-020-2488-132604404Search in Google Scholar
Rumain B., Schneiderman M., Geliebter A.: Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surges. PLoS ONE, 16, e0242587 (2021)RumainB.SchneidermanM.GeliebterA.Prevalence of COVID-19 in adolescents and youth compared with older adults in states experiencing surgesPLoS ONE16e0242587202110.1371/journal.pone.0242587794618933690600Search in Google Scholar
Omori R., Matsuyama R., Nakata Y.: The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age. Nat Sci Rep. 10, 16642 (2020)OmoriR.MatsuyamaR.NakataY.The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by ageNat Sci Rep1016642202010.1038/s41598-020-73777-8753891833024235Search in Google Scholar
Wu Z., McGoogan J.M.: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA, 323, 1239–1242 (2020)WuZ.McGooganJ.M.Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and preventionJAMA32312391242202010.1001/jama.2020.264832091533Search in Google Scholar
Aoyagi Y., Inamoto Y., Shibata S., Kagaya H., Otaka Y., Saitoh E.: Clinical manifestation, evaluation, and rehabilitative strategy of dysphagia associated with COVID-19. Am J Phys Med Rehabil. 100, 424–431 (2021)AoyagiY.InamotoY.ShibataS.KagayaH.OtakaY.SaitohE.Clinical manifestation, evaluation, and rehabilitative strategy of dysphagia associated with COVID-19Am J Phys Med Rehabil100424431202110.1097/PHM.0000000000001735803221733657028Search in Google Scholar
Mao L., Hu B. et al.: Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77, 683–690 (2021).MaoL.HuB.Neurological manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, ChinaJAMA Neurol77683690202110.1001/jamaneurol.2020.1127714936232275288Search in Google Scholar
Zimmer M.A., Zink A.K., Weiber C.W., Vogt U., Michelsen A., Priebe H.J., Mols G.: Hypernatremia – A manifestation of COVID-19: A case series. A A Pract. 14(9), e01295 (2020)ZimmerM.A.ZinkA.K.WeiberC.W.VogtU.MichelsenA.PriebeH.J.MolsG.Hypernatremia – A manifestation of COVID-19: A case seriesA A Pract149e01295202010.1213/XAA.0000000000001295740952432909725Search in Google Scholar
Iranmanesh B., Khalili M., Amiri R., Zartab H., Aflatoonian M.: Oral manifestations of COVID-19 disease: A review article. Dermatol Ther. 34, e14578 (2021)IranmaneshB.KhaliliM.AmiriR.ZartabH.AflatoonianM.Oral manifestations of COVID-19 disease: A review articleDermatol Ther34e14578202110.1111/dth.14578774490333236823Search in Google Scholar
Yildirim A.C., Ceviker S.A., Zeren S., Ekici M.F., Yaylak F., Algin M.C., Özlem A.R.I.K.: COVID-19 and related gastrointestinal symptoms: An observational study. Marmara Medical Journal, 35(2), pp. 244–248 (2022)YildirimA.C.CevikerS.A.ZerenS.EkiciM.F.YaylakF.AlginM.C.ÖzlemA.R.I.K.COVID-19 and related gastrointestinal symptoms: An observational studyMarmara Medical Journal352244248202210.5472/marumj.1121879Search in Google Scholar
Wu P., Duan F., Luo C., Liu Q., Qu X., Liang L., Wu K.: Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 138, 575–578 (2020)WuP.DuanF.LuoC.LiuQ.QuX.LiangL.WuK.Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, ChinaJAMA Ophthalmol138575578202010.1001/jamaophthalmol.2020.1291711091932232433Search in Google Scholar
Tan S.W., Tam Y.C., Oh C.C.: Skin manifestations of COVID-19: A worldwide review. JAAD Int. 2, 119–133 (2021)TanS.W.TamY.C.OhC.C.Skin manifestations of COVID-19: A worldwide reviewJAAD Int2119133202110.1016/j.jdin.2020.12.003775487933479703Search in Google Scholar
Nepal G., Rehrig J.H., Shrestha G.S., Shing Y.K., Yadav J.K., Ojha R., Pokhrel G., Tu Z.L., Huang D.Y.: Neurological manifestations of COVID-19: a systematic review. Crit Care, 24, 421 (2020)NepalG.RehrigJ.H.ShresthaG.S.ShingY.K.YadavJ.K.OjhaR.PokhrelG.TuZ.L.HuangD.Y.Neurological manifestations of COVID-19: a systematic reviewCrit Care24421202010.1186/s13054-020-03121-z735613332660520Search in Google Scholar
Li X., Zhao J. et al.: Risk factors for severity and mortality in adults COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 146, 110–118 (2020)LiX.ZhaoJ.Risk factors for severity and mortality in adults COVID-19 inpatients in WuhanJ Allergy Clin Immunol146110118202010.1016/j.jaci.2020.04.006715287632294485Search in Google Scholar
Guo L., Shi Z., Zhang Y., Wang C., Moreira N.C.D.V., Zuo H., Hussain A.: Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysis. Diab Res Clin Pract. 166, 108346 (2020)GuoL.ShiZ.ZhangY.WangC.MoreiraN.C.D.V.ZuoH.HussainA.Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: A meta-analysisDiab Res Clin Pract166108346202010.1016/j.diabres.2020.108346737528732710998Search in Google Scholar
Gao F., Zheng K.I., Wang X.B., Sun Q.F., Pan K.H., Wang T.Y., Chen Y.P., Targher G., Byrne C.D., George J., Zheng M.H.: Obesity is a risk factor for greater COVID-19 severity. Diabetes Care, 43, e72–e74 (2020)GaoF.ZhengK.I.WangX.B.SunQ.F.PanK.H.WangT.Y.ChenY.P.TargherG.ByrneC.D.GeorgeJ.ZhengM.H.Obesity is a risk factor for greater COVID-19 severityDiabetes Care43e72e74202010.2337/dc20-068232409499Search in Google Scholar
Zhu Z., Hasegawa K., Ma B., Fujiogi M., Camargo Jr C.A., Liang L.: Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 146(2), 327–329 (2020)ZhuZ.HasegawaK.MaB.FujiogiM.CamargoC.A.JrLiangL.Association of asthma and its genetic predisposition with the risk of severe COVID-19J Allergy Clin Immunol1462327329202010.1016/j.jaci.2020.06.001742360232522462Search in Google Scholar
Attaway A.A., Zein J., Hatipoglu U.S.: SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registry. EClinicalMedicine, 26, 100515 (2020)AttawayA.A.ZeinJ.HatipogluU.S.SARS-CoV-2 infection in the COPD population is associated with increased healthcare utilization: An analysis of Cleveland clinic's COVID-19 registryEClinicalMedicine26100515202010.1016/j.eclinm.2020.100515744966332869011Search in Google Scholar
Hoffmann M., Pohlmann S. et al.: SARS-CoV-2 entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181, 271–280 (2020)HoffmannM.PohlmannS.SARS-CoV-2 entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitorCell181271280202010.1016/j.cell.2020.02.052710262732142651Search in Google Scholar
Brosnahan S.B., Jonkman A.H., Kugler M.C., Munger J.S., Kaufman D.A.: COVID-19 and respiratory system disorders. Current knowledge, future clinical and translational research questions. Arterioscler Thromb Vasc Biol. 40, 2586–2597 (2020)BrosnahanS.B.JonkmanA.H.KuglerM.C.MungerJ.S.KaufmanD.A.COVID-19 and respiratory system disorders. Current knowledge, future clinical and translational research questionsArterioscler Thromb Vasc Biol4025862597202010.1161/ATVBAHA.120.314515757184632960072Search in Google Scholar
Gattinoni L., Chiumello D., Caironi P., Busana M., Romitti F., Brazzi L., Camporota L.: COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 46, 1099–1102 (2020)GattinoniL.ChiumelloD.CaironiP.BusanaM.RomittiF.BrazziL.CamporotaL.COVID-19 pneumonia: different respiratory treatments for different phenotypes?Intensive Care Med4610991102202010.1007/s00134-020-06033-2715406432291463Search in Google Scholar
Bai H.X., Liao W.H. et al.: Artificial intelligence augmentation of radiologist performance in distinguishing COVID-19 from pneumonia of other origin at chest CT. Radiology, 296, E156 E165 (2020)BaiH.X.LiaoW.H.Artificial intelligence augmentation of radiologist performance in distinguishing COVID-19 from pneumonia of other origin at chest CTRadiology296E156E165202010.1148/radiol.2020201491723348332339081Search in Google Scholar
Tang N.L., Chan P.K., Wong C.K., To K.F., Wu A.K., Sung Y.M., Hui D.S., Sung J.J., Lam C.W.: Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem. 51, 2333–2340 (2005)TangN.L.ChanP.K.WongC.K.ToK.F.WuA.K.SungY.M.HuiD.S.SungJ.J.LamC.W.Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndromeClin Chem5123332340200510.1373/clinchem.2005.054460710814616195357Search in Google Scholar
Wang J., Nikrad M.P., Phang T., Gao B., Alford T., Ito Y., Edeen K., Travanty E.A., Kosmider B., Hartshorn K., Mason R.J.: Innate immune response to influenza A virus in differentiated human alveolar. American journal of respiratory cell and molecular biology, 45(3), pp.582–591 (2011)WangJ.NikradM.P.PhangT.GaoB.AlfordT.ItoY.EdeenK.TravantyE.A.KosmiderB.HartshornK.MasonR.J.Innate immune response to influenza A virus in differentiated human alveolarAmerican journal of respiratory cell and molecular biology453582591201110.1165/rcmb.2010-0108OC317557621239608Search in Google Scholar
Middeldorp S., Coppens M., van Haaps T.F., Foppen M., Vlaar A.P., Muller M.C.A., Bouman C.C.S., Beenen L.F.M., Kootte R.S., Heijmans J., Smits L.P., Bonta P.I., van Es N.: Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 18, 1995–2002 (2020)MiddeldorpS.CoppensM.van HaapsT.F.FoppenM.VlaarA.P.MullerM.C.A.BoumanC.C.S.BeenenL.F.M.KootteR.S.HeijmansJ.SmitsL.P.BontaP.I.van EsN.Incidence of venous thromboembolism in hospitalized patients with COVID-19J Thromb Haemost1819952002202010.1111/jth.14888749705232369666Search in Google Scholar
Fraser E.: Long term respiratory complications of covid-19. BMJ, 370, m3001 (2020)FraserE.Long term respiratory complications of covid-19BMJ370m3001202010.1136/bmj.m300132747332Search in Google Scholar
British Thoracic Society.: Guidance on respiratory follow up of patients with a clinico-radiological diagnosis of covid-19 pneumonia. 2020. www.brit-thoracic.org.ukBritish Thoracic SocietyGuidance on respiratory follow up of patients with a clinico-radiological diagnosis of covid-19 pneumonia2020www.brit-thoracic.org.ukSearch in Google Scholar
Guan W.J, He J.X. et al.: China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 55, 2000547 (2020)GuanW.J.HeJ.X.China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisEur Respir J552000547202010.1183/13993003.00547-2020709848532217650Search in Google Scholar
Pranata R., Soeroto A.Y., Huang I., Lim M.A., Santoso P., Permana H., Lukito A.A.: Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19. Int J Tuberc Lung Dis. 24, 838–843 (2020)PranataR.SoerotoA.Y.HuangI.LimM.A.SantosoP.PermanaH.LukitoA.A.Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19Int J Tuberc Lung Dis24838843202010.5588/ijtld.20.027832912389Search in Google Scholar
Lofus P.A., and Wise S.K.: Epidemiology of asthma. Curr Opin Otolaryngol Head Neck Surg. 24, 245–249 (2016)LofusP.A.WiseS.K.Epidemiology of asthmaCurr Opin Otolaryngol Head Neck Surg24245249201610.1097/MOO.000000000000026226977741Search in Google Scholar
McCracken J.L., Veeranki S.P., Ameredes B.T., Calhoun W.J.: Diagnosis and management of asthma in adults: A review. JAMA, 318, 279–290 (2017)McCrackenJ.L.VeerankiS.P.AmeredesB.T.CalhounW.J.Diagnosis and management of asthma in adults: A reviewJAMA318279290201710.1001/jama.2017.837228719697Search in Google Scholar
Gaga M., and Zervas E.: Oral steroids in asthma: a double-edged sword. Eur Respir J. 54, 1902034 (2019)GagaM.ZervasE.Oral steroids in asthma: a double-edged swordEur Respir J541902034201910.1183/13993003.02034-201931780458Search in Google Scholar
Nicholson K.G., Kent J., Ireland D.C.: Respiratory viruses and exacerbations of asthma in adults. BMJ, 307, 982–986 (1993)NicholsonK.G.KentJ.IrelandD.C.Respiratory viruses and exacerbations of asthma in adultsBMJ307982986199310.1136/bmj.307.6910.98216791938241910Search in Google Scholar
Abrams E.M., Jong G.W., Yang C.L.: Asthma and COVID-19. CMAJ, 192, E551 (2020)AbramsE.M.JongG.W.YangC.L.Asthma and COVID-19CMAJ192E551202010.1503/cmaj.200617724188332332038Search in Google Scholar
Ruan Q., Yang K., Wang W., Jiang L., Song J.: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; 46, 846–848 (2020)RuanQ.YangK.WangW.JiangL.SongJ.Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, ChinaIntensive Care Med2020;46846848202010.1007/s00134-020-05991-x708011632125452Search in Google Scholar
Shabrawishi M., Alwafi H. et al. Clinical, radiological, and therapeutic characteristics of patients with COVID-19 in Saudi Arabia. PLoS One, 15, e0237130 (2020)ShabrawishiM.AlwafiH.Clinical, radiological, and therapeutic characteristics of patients with COVID-19 in Saudi ArabiaPLoS One15e0237130202010.1371/journal.pone.0237130741024632760107Search in Google Scholar
Rezende L.F.M., Thome B., Schveitzer M.C., Souza-, Junior P.B de, Szwarcwald C.L.: Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil. Revista De Saúde Pública, 54, 50 (2020).RezendeL.F.M.ThomeB.SchveitzerM.C.SouzaP.B deJuniorSzwarcwaldC.L.Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in BrazilRevista De Saúde Pública5450202010.11606/s1518-8787.2020054002596Search in Google Scholar
Borobia A.M., Arribas J.R. et al.: On behalf of the Covid Hulp Working Group. A cohort of patients with COVID-19 in a major teaching hospital in Europe. J Clin Med. 9, 1733 (2020)BorobiaA.M.ArribasJ.R.On behalf of the Covid Hulp Working Group. A cohort of patients with COVID-19 in a major teaching hospital in EuropeJ Clin Med91733202010.3390/jcm9061733Search in Google Scholar
Izquierdo J.L., Almonacid C., Gonzalez Y., Rio-Bermudez C.D., Ancochea J., Cardenas R., Lumbreras S., Soriano J.B.: The impact of covid-19 on patients with asthma. Eur Respir J. 57, 2003142 (2020)IzquierdoJ.L.AlmonacidC.GonzalezY.Rio-BermudezC.D.AncocheaJ.CardenasR.LumbrerasS.SorianoJ.B.The impact of covid-19 on patients with asthmaEur Respir J572003142202010.1183/13993003.03142-2020Search in Google Scholar
Chhiba K.D., Patel G.B., Vu T.H.T., Chen M.M., Guo A., Kudlaty E., Mai Q., Yeh C., Muhammad L.N., Harris K.E., Bochner B.S., Grammer L.C., Greenberger P.A., Kalhan R., Kuang F.L., Saltoun C.A., Schleimer R.P., Stevens W.W., Peters A.T.: Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 146, 307–314 (2020)ChhibaK.D.PatelG.B.VuT.H.T.ChenM.M.GuoA.KudlatyE.MaiQ.YehC.MuhammadL.N.HarrisK.E.BochnerB.S.GrammerL.C.GreenbergerP.A.KalhanR.KuangF.L.SaltounC.A.SchleimerR.P.StevensW.W.PetersA.T.Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19J Allergy Clin Immunol146307314202010.1016/j.jaci.2020.06.010Search in Google Scholar
Zhang J.J., Dong X., Cao Y.Y., Yuan Y.D., Yang Y.B., Yan Y.Q., Akdis C.A., Gao Y.D.: Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy, 75, 1730–1741 (2020)ZhangJ.J.DongX.CaoY.Y.YuanY.D.YangY.B.YanY.Q.AkdisC.A.GaoY.D.Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, ChinaAllergy7517301741202010.1111/all.14238Search in Google Scholar
Chen N., Zhang L. et al.: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 395, 507–513 (2020).ChenN.ZhangL.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive studyLancet395507513202010.1016/S0140-6736(20)30211-7Search in Google Scholar
Grandbastien M., de Blay F. et al.: SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation. J Allergy Clin Immunol Pract. 8, 2600–2607 (2020)GrandbastienM.de BlayF.SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbationJ Allergy Clin Immunol Pract826002607202010.1016/j.jaip.2020.06.032732086932603901Search in Google Scholar
Docherty A.B., Semple M.G. et al.: Features of 16,749 hospitalized UK patients with COVID-19 using the ISARIC WHO clinical characterization protocol. BMJ, 2020 (2020).DochertyA.B.SempleM.G.Features of 16,749 hospitalized UK patients with COVID-19 using the ISARIC WHO clinical characterization protocolBMJ2020,202010.1136/bmj.m1985724303632444460Search in Google Scholar
CDC COVID-19 Response Team.: Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 – United States, February 12 – March 28, 2020. MMWR Morb Mortal Wkly Rep. 69, 382–386 (2020)CDC COVID-19 Response TeamPreliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 – United States, February 12 – March 28, 2020MMWR Morb Mortal Wkly Rep69382386202010.15585/mmwr.mm6913e2711951332240123Search in Google Scholar
Carli G., Cecchi L., Stebbing J., Parronchi P., Farsi A.: Is asthma protective against COVID-19? Allergy, 2020 (2020).CarliG.CecchiL.StebbingJ.ParronchiP.FarsiA.Is asthma protective against COVID-19?Allergy2020202010.1111/all.14426730071232479648Search in Google Scholar
Ferastraoaru D., Hudes G., Jerschow E., Jariwala S., Karagic M., Vos G de., Rosenstreich D., Ramesh M.: Eosinophilia in asthma patients is protective against severe COVID-19 illness. J Allergy Clin Immunol Pract. 9, 1152–1162 (2021)FerastraoaruD.HudesG.JerschowE.JariwalaS.KaragicM.VosG de.RosenstreichD.RameshM.Eosinophilia in asthma patients is protective against severe COVID-19 illnessJ Allergy Clin Immunol Pract911521162202110.1016/j.jaip.2020.12.045782603933495097Search in Google Scholar
Hughes-Visentin A., Paul A.B.M.: Asthma and COVID-19: What do we know now. Clin Med Insights Circ Respir Pulm Med. 14, 1179548420966242 (2020).Hughes-VisentinA.PaulA.B.M.Asthma and COVID-19: What do we know nowClin Med Insights Circ Respir Pulm Med141179548420966242202010.1177/1179548420966242758876033173369Search in Google Scholar
Halpin D.M.G., Singh D., Hadfield R.M.: Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective. Eur Respir J. 55(5), 2001009 (2020)HalpinD.M.G.SinghD.HadfieldR.M.Inhaled corticosteroids and COVID-19: a systematic review and clinical perspectiveEur Respir J5552001009202010.1183/13993003.01009-2020723682832341100Search in Google Scholar
Farne H., Singanayagam A.: Why asthma might surprisingly protect against poor outcomes in COVID-19. Eur Respir J. 56(6), 2003045 (2020).FarneH.SinganayagamA.Why asthma might surprisingly protect against poor outcomes in COVID-19Eur Respir J5662003045202010.1183/13993003.03045-2020765183833154034Search in Google Scholar
Sajuthi S.P., Seibold M.A. et al.: Type 2 and interferon inflammation strongly regulates SARS-CoV-2 related gene expression in the airway epithelium. Nat Comm. 11, 5139 (2020)SajuthiS.P.SeiboldM.A.Type 2 and interferon inflammation strongly regulates SARS-CoV-2 related gene expression in the airway epitheliumNat Comm115139202010.1101/2020.04.09.034454723905632511326Search in Google Scholar
Alsofayan Y.M., Althunayyan S.M., Khan A.A., Hakawi A.M., Assiri A.M.: Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public Health, 13, 920–925 (2020).AlsofayanY.M.AlthunayyanS.M.KhanA.A.HakawiA.M.AssiriA.M.Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective studyJ Infect Public Health13920925202010.1016/j.jiph.2020.05.026783306332534945Search in Google Scholar
Shaker M.S., Greenhawt M. et al.: COVID-19: Pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 8(5), 1477–1488 (2020)ShakerM.S.GreenhawtM.COVID-19: Pandemic contingency planning for the allergy and immunology clinicJ Allergy Clin Immunol Pract8514771488202010.1016/j.jaip.2020.03.012719508932224232Search in Google Scholar
Levin M., Wong G.W.K. et al.: Acute asthma management during SARS-CoV-2 pandemic 2020. World Allergy Org J. 13(5), 100125 (2020)LevinM.WongG.W.K.Acute asthma management during SARS-CoV-2 pandemic 2020World Allergy Org J135100125202010.1016/j.waojou.2020.100125722136532411315Search in Google Scholar
Corman V.M., Muth D., Niemeyer D., Drosten C.: Hosts and sources of endemic human coronaviruses. Adv Virus Res. 100, 163–188 (2018)CormanV.M.MuthD.NiemeyerD.DrostenC.Hosts and sources of endemic human coronavirusesAdv Virus Res100163188201810.1016/bs.aivir.2018.01.001711209029551135Search in Google Scholar
Guan Y., Poon L.L.M. et al.: Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. In: Learning from SARS: Preparing for the next disease outbreak: Workshop summary. Institute of Medicine (US) Forum on Microbial Threats; Knobler S, Mahmoud A, Lemon S, et al., editors. Washington (DC): National Academies Press (US); 2004.GuanY.PoonL.L.M.Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern ChinaIn:Learning from SARS: Preparing for the next disease outbreak: Workshop summary. Institute of Medicine (US) Forum on Microbial ThreatsKnoblerSMahmoudALemonSeditors.Washington (DC)National Academies Press (US)200410.1126/science.108713912958366Search in Google Scholar
